Skip to main content
. 2022 Nov 15;13:1022785. doi: 10.3389/fneur.2022.1022785

Figure 1.

Figure 1

Patients selection process. Anti-NMDAR encephalitis, anti-N-methyl-D-aspartate receptor encephalitis.